Effect of therapeutic macromolecules in spheroids

Area of Science:

• Biotechnology and Cancer Therapeutics
• 3-D Tumor Models

Background:

• Biotechnology advances have produced novel macromolecular therapeutic agents, including antibodies, immunotoxins, cytokines, extracellular matrix (ECM) proteins, and vectors.
• These agents hold promise for treating human tumors and other diseases.

Purpose of the Study:

• To review the use of Multicellular Tumor Spheroids (MTS) as a 3-D model for evaluating macromolecular therapeutic agents.
• To discuss the delivery, penetration, and therapeutic effects of these agents within the MTS model.

Main Methods:

• Utilizing the Multicellular Tumor Spheroids (MTS) model to simulate a 3-D tumor environment.
• Investigating the behavior of macromolecules, such as antibodies and immunotoxins, within the MTS model.
• Analyzing factors like binding site barriers and cell-matrix interactions in 3-D.

Main Results:

• The MTS model is a valuable tool for assessing the therapeutic potential of novel macromolecular agents in a 3-D context.
• The review highlights significant findings on the delivery and penetration of various macromolecules, including antibodies and immunotoxins, into MTS.
• The study addresses specific behaviors of macromolecules in 3-D, such as binding site barriers and the influence of cell-cell and cell-ECM interactions.

Conclusions:

• Multicellular Tumor Spheroids (MTS) provide a relevant platform for preclinical evaluation of macromolecular therapeutics.
• Understanding macromolecule behavior in 3-D is crucial for optimizing their clinical application in cancer treatment.
• The MTS model facilitates the study of complex interactions influencing therapeutic efficacy.